Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm-Reference-Cited by-同舟云学术

Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm

Published:2021-04-29 Issue:5 Volume:5 Page:e555
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Baronciani Donatella,Casale Maddalena,De Franceschi Lucia,Graziadei Giovanna,Longo Filomena,Origa Raffaella,Rigano Paolo,Pinto Valeria,Marchetti Monia,Gigante Antonia,Forni Gian Luca

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference60 articles.

1. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.;Cavazzana-Calvo;Nature,2010

2. Gene Therapy in patients with transfusion-dependent β-thalassemia.;Thompson;N Engl J Med,2018

3. Gene therapy of the hemoglobinopathies.;Kunz;HemaSphere,2020

4. Marrow transplantation in patients with advanced thalassemia.;Lucarelli;N Engl J Med,1987

5. Bone marrow transplantation in patients with thalassemia.;Lucarelli;N Engl J Med,1990

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First and Second Level Haemoglobinopathies Diagnosis: Best Practices of the Italian Society of Thalassemia and Haemoglobinopathies (SITE);Journal of Clinical Medicine;2022-09-15

2. Hurdles to the Adoption of Gene Therapy as a Curative Option for Transfusion-Dependent Thalassemia;Stem Cells Translational Medicine;2022-03-10

3. Advancing the care of β-thalassaemia patients with novel therapies;BLOOD TRANSFUS-ITALY;2022

4. 2021 update on clinical trials in β‐thalassemia;American Journal of Hematology;2021-08-18

5. Correction Notice: Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm;HemaSphere;2021-07-20